Charles River Laboratories International, Inc. (CRL): Price and Financial Metrics
Charles River Laboratories International, Inc. (CRL)
Today's Latest Price: $136.12 USD
Updated Apr 7 9:41am
Add CRL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
CRL Stock Summary
- CRL has a market capitalization of $5,391,428,509 -- more than approximately 82.73% of US stocks.
- CRL's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 402.5 -- higher than 92.61% of US-listed equities with positive expected earnings growth.
- In terms of volatility of its share price, CRL is more volatile than only 19.29% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Charles River Laboratories International Inc, a group of peers worth examining would be PRAH, HURN, EXLS, FDS, and G.
- CRL's SEC filings can be seen here. And to visit Charles River Laboratories International Inc's official web site, go to www.criver.com.
CRL Stock Price Chart More Charts
CRL Price/Volume Stats
| Current price | $136.12 | 52-week high | $179.38 |
| Prev. close | $132.81 | 52-week low | $95.58 |
| Day low | $135.68 | Volume | 9,665 |
| Day high | $137.92 | Avg. volume | 473,181 |
| 50-day MA | $145.24 | Dividend yield | N/A |
| 200-day MA | $140.30 | Market Cap | 6.74B |
Charles River Laboratories International, Inc. (CRL) Company Bio
Charles River Laboratories provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company was founded in 1947 and is based in Wilmington, Massachusetts.
CRL Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $136.12 | $131.65 | -1% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Charles River Laboratories International Inc. To summarize, we found that Charles River Laboratories International Inc ranked in the 40th percentile in terms of potential gain offered. The most interesting components of our discounted cash flow analysis for Charles River Laboratories International Inc ended up being:
- 77% of the company's capital comes from equity, which is greater than 60.11% of stocks in our cash flow based forecasting set.
- The weighted average cost of capital for the company is 7. This value is greater than merely 12.07% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -3% |
| 1% | -2% |
| 2% | -1% |
| 3% | 0% |
| 4% | 1% |
| 5% | 2% |
Want more companies with a valuation profile/forecast similar to that of Charles River Laboratories International Inc? See ARNA, GILD, MD, PDLI, and DXCM.
Top Stories View All
Best & Worst Performing Stock Industries for April 6, 2020
Best & Worst Performing Small Cap Stocks for April 6, 2020
Best & Worst Performing Mid Cap Stocks for April 6, 2020
Best & Worst Performing Large Cap Stocks for April 6, 2020
Best & Worst Performing Mega Cap Stocks for April 6, 2020
View All Top Stories
Loading social stream, please wait...